Who Should Not Take Semaglutide

Wondering who should not take semaglutide? Learn about medical conditions, contraindications, and safety precautions that may impact GLP-1 eligibility.

Key takeaways
  • Avoid semaglutide if you have a history of medullary thyroid carcinoma or MEN 2 syndrome¹
  • It’s not recommended during pregnancy or breastfeeding²
  • Use caution in pancreatitis, kidney, or liver disease³
  • Always use under the supervision of a licensed healthcare provider

Semaglutide is a GLP-1 receptor agonist FDA-approved for managing type 2 diabetes and chronic weight issues. While widely used and effective, it’s not appropriate for everyone.If you're wondering who should not take semaglutide, this guide explains medical contraindications, precautions, and why full provider evaluation is essential before starting therapy.

Is GLP-1 Treatments right for you?

Is GLP-1 Treatments right for you?

Get started

How Semaglutide Works

Semaglutide mimics GLP-1, a hormone released in response to eating. It supports:

  • Insulin secretion when glucose is high
  • Glucagon suppression to reduce liver glucose output
  • Delayed gastric emptying
  • Appetite suppression

This makes it effective for glucose control and weight reduction when paired with lifestyle support.

Who Should Not Take Semaglutide

1. Thyroid Cancer or MEN 2 Syndrome
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2)¹.

2. Pregnancy and Breastfeeding
Semaglutide is not recommended in pregnancy or during lactation². It should be discontinued at least 2 months before trying to conceive.

3. History of Pancreatitis
Cases of acute pancreatitis have been reported following semaglutide use³ . Patients with prior episodes should be evaluated carefully.

4. Severe Kidney or Liver Disease
Caution is advised in patients with moderate to severe renal or hepatic impairment, especially transplant recipients.

5. Known Allergic Reactions
Avoid semaglutide in known allergy to the drug or its components.

Use With Caution: Special Considerations

Patients may still qualify for semaglutide but require provider supervision if:

  • Using insulin or sulfonylureas (risk of hypoglycemia)
  • Having GI disorders like gastroparesis
  • Managing thyroid disease or taking multiple medications

Conditions Requiring Pre-Screening

Kidney & Liver Function

  • Creatinine, eGFR, and liver enzyme levels should be evaluated

Cardiovascular Evaluation

  • Semaglutide may improve cardiovascular outcomes, but heart rhythm concerns may warrant individualization¹

Disclose Your Full Health History

Before starting semaglutide, share:

  • Thyroid cancer, pancreatitis, or GI history
  • Pregnancy or conception plans
  • Current medications and allergies
  • Kidney and liver function data

When to Consider Alternatives

Your provider may suggest:

  • Different GLP-1 RAs
  • Metformin, SGLT2 inhibitors
  • Lifestyle-focused non-drug options

How Eden Can Help

Eden connects you with:

  • Licensed GLP-1 prescribers
  • Medical history screening
  • Personalized dose guidance and lifestyle support

Final Thoughts

Who should not take semaglutide? Patients with MTC, pancreatitis, pregnancy, or significant organ disease may need to avoid or delay use. With professional evaluation, semaglutide can be safe and effective for the right candidates.

Disclaimer

This content is for informational purposes and is not a substitute for medical advice. Always consult a licensed provider before starting or stopping any medication.

Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.

Frequently asked questions

GLP-1 Treatments
Personalized doctor-led plans
As low as $196/mo*
Get started
Important safety information
Important safety information
Verified Customer
"I had an incredible experience, and the support that Eden provides is 10/10"
Kerstin
Verified Customer
“I had so many questions in the beginning, and both the doctor and customer support were so patient and thorough.”
Lane L.

Is GLP-1 Treatments right for you?

Is GLP-1 Treatments right for you?

Get started

References

  1. Smits, M. M., & van Raalte, D. H. (2021). Safety of Semaglutide. Frontiers in Endocrinology, 12, 645563. https://doi.org/10.3389/FENDO.2021.645563 
  2. Skov, K., Mandic, I. N., & Nyborg, K. M. (2023). Semaglutide and pregnancy. https://doi.org/10.1002/ijgo.15092 
  3. Hughes, K., Kurrun Sumaruth, Y. R., Mohammed, E., & Bakshsingh, V. S. (2024). Acute Pancreatitis Likely Due to Semaglutide. Cureus. https://doi.org/10.7759/cureus.69844 
  4. Princy, R. (2024). Semaglutide induced Pancreatitis. International Journal For Multidisciplinary Research, 6(4). https://doi.org/10.36948/ijfmr.2024.v06i04.26238 
  5. Attallah, N., & Yassine, L. (2022). P8.087: Semaglutide May Be Safe After Kidney Transplant. Transplantation, 106(9S), S591. https://doi.org/10.1097/01.tp.0000888732.07133.a9